august 2020
COVID-19 vaccine well tolerated, generates immune response
KPWHRI is leading the National Institute of Allergy and Infectious Diseases-sponsored phase 1 trial testing mRNA vaccine.
Decades in the making: A look back at what makes MacColl, MacColl
Upon retirement, MacColl Center co-founder Brian Austin reflects on how the Center became a global pioneer in health care transformation.
Benefit of 3D mammogram less with very dense breasts
But for most women, digital breast tomosynthesis improves cancer detection and reduces recalls, writes Dr. Yates Coley.
Integrating personalized and population medicine
In JAMA, Kaiser Permanente and PCORI experts outline principles for applying genomic data to community health.
New Lancet report offers hope for preventing dementia
Dr. Eric B. Larson, a report contributor, answers questions about reducing risks, disparities, and threats from COVID-19.
COVID-19 pandemic research at KPWHRI
Having long tracked infectious diseases and tested vaccines for safety and effectiveness, KPWHRI now focuses on the novel coronavirus.
Recognition
Get social with us
More KPWHRI News
Suggestions?
Please send comments or suggestions to Communications Director Joan DeClaire at Joan.M.Declaire@kp.org.
